To test whether the potential role of the USP3-SMARCA5 axis may as a target for cancer therapy, we silenced USP3 or SMARCA5 individually or together in PC3 cells or DU145 cells (Fig. 6A, B: left), and examined the cell survival following docetaxel. The gene discussed is SMARCA5; the disease is cancer.